Legal & General Group
RBOT

Legal & General Group’s Vicarious Surgical RBOT Stock Holding History

Legal & General Group’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-246
Closed -$2.22K – 3491
2024
Q1 		$2.22K Hold
246
– – ﹤0.01% 3344
2023
Q4 		$2.7K Hold
246
– – ﹤0.01% 3354
2023
Q3 		$4.35K Hold
246
– – ﹤0.01% 3369
2023
Q2 		$13.5K Buy
246
+13
+6% +$828 ﹤0.01% 3261
2023
Q1 		$15.9K Hold
233
– – ﹤0.01% 3130
2022
Q4 		$14.1K Sell
233
-25,103
-99% -$2.33M ﹤0.01% 3215
2022
Q3 		$2.55M Buy
25,336
+777
+3% +$90.5K ﹤0.01% 1736
2022
Q2 		$2.17M Sell
24,559
-2,107
-8% -$258K ﹤0.01% 1849
2022
Q1 		$4.05M Sell
26,666
-305
-1% -$56.7K ﹤0.01% 1636
2021
Q4 		$8.59M Buy
+26,971
New +$9.51M ﹤0.01% 1293

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group's RBOT Position: Q2 2024 in Review

Legal & General Group sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 246 shares — an estimated $2.22K sold.

Legal & General Group first reported a position in RBOT in Q4 2021 and held it in 10 quarters. The position peaked at $8.59M in Q4 2021. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • Legal & General Group reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 246 Vicarious Surgical shares in Q2 2024, an estimated $2.22K.
  • Legal & General Group first reported a position in Vicarious Surgical in Q4 2021 and held it in 10 quarters.
  • Legal & General Group's Vicarious Surgical position peaked at $8.59M in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.